ICICI Lombard Q1 PAT falls 46% YoY to ₹403 Cr as claims spike, ₹165 Cr motor reserve bites
PAT -46% YoY · revenue +12% · margins compressing
₹6,807.91 Cr
+12% YoY
₹403.17 Cr
-46% YoY
5.92%
-6.4pp YoY
₹8.08
ICICI Lombard reported standalone Q1 FY27 (Jun-2026) PAT of ₹403.17 Cr, down 46.0% YoY from ₹747.08 Cr and 26.2% QoQ from ₹546.56 Cr, even as total income rose ~12% YoY to ₹6,813.71 Cr on net premium earned of ₹5,950 Cr (+15.8% YoY). Net margin compressed sharply to 5.9% from 12.3% a year ago. Basic EPS halved to ₹8.08 from ₹15.06. The print is weak on the bottom line despite healthy premium growth.
Q1 FY-2027 vs prior quarters
The profit fall is only partly a one-off. The company booked a prudent, conservative ₹165 Cr claim reserve on its Motor Third-Party book following the Supreme Court's June 11 2026 ruling recognising the economic value of homemakers' unpaid work for MV Act compensation; the GI Council has filed a review petition (Jul 10). Adjusting that back post-tax (~₹124 Cr) lifts PAT to ~₹527 Cr — still roughly 29% below the year-ago base, so the deterioration is structural, not cosmetic. The combined ratio worsened to 102.7% (vs 102.0% YoY, 101.2% QoQ) and the incurred-claims ratio rose to 76.4% from 73.0%, while operating investment income slipped 9% YoY to ₹857.9 Cr — the three drivers of the squeeze. Segmentally, Motor underwriting loss widened to ₹245.2 Cr (from ₹106 Cr YoY, where the TP reserve sits) and Health Group/Corporate stayed loss-making at ₹301.7 Cr.
The stock went into the print at ₹1,814.6, up 4.3% over the past month of trading.
For context: revenue is at a 5-quarter high.
Management anticipates the strong growth momentum from H2 FY26 to continue into early FY27, driven by Motor and exceptional growth in Retail Health. However, they explicitly warn of persistent and elevated pricing pressure in the Commercial lines segment, which is expected to continue in Q1 FY27 and could mute overall
— This quarter: missed
Against management's own Q4-FY26 concall guidance — strong growth into early FY27 led by Motor and Retail Health, disciplined Motor loss ratio of 65-67% and Retail Health 65-70% — the topline held (premiums grew double-digit and Retail Health net premium earned jumped ~50% YoY to ₹677 Cr) but the profitability targets were missed, with the combined ratio above breakeven and Motor loss ratios stretched by the reserve. The prior-call warning on Commercial-lines pricing pressure appears borne out in the weaker underwriting result. No published Street PAT consensus for the quarter was found (results released today); analyst 12-month targets cluster near ₹2,200. Alongside results, the board extended CIO Vinod Mahajan's tenure to Apr-2029 and confirmed the ₹7/share FY26 final dividend (approved at the Jun-19 AGM).
What to watch
W1
Combined ratio path: 102.7% in Q1 must fall toward <100% for underwriting to turn; guidance implied Motor loss ratio 65-67%
W2
Motor-TP reserve outcome: GI Council review petition (filed Jul 10 2026) on the SC ruling — could reverse or require further ₹165 Cr-type reserving
W3
Retail Health momentum (+~50% YoY net premium earned) vs its 65-70% loss-ratio target — key swing factor for FY27 profitability
Insurance two-account format (in Lakhs). revenueFromOps = net premium earned ₹5,950.04 Cr + operating investment income ₹857.87 Cr; +otherIncome ₹5.80 Cr = totalIncome ₹6,813.71 Cr (line 6). totalExpenses ₹6,579.92 Cr (line 12) yields operating profit ₹233.79 Cr; PBT ₹535.70 Cr is higher as it adds shareholders'-account investment income (~₹302 Cr), so totalIncome−totalExpenses≠PBT by design. PAT=PBT−tax checks. One-off: ₹165 Cr prudent Motor-TP claim reserve booked this quarter (SC homemakers-compensation ruling, Jun 11 2026); GI Council filed review petition Jul 10. No consolidated statement (standalone insurer).
Profitability crashed 46%, Motor TP judgement a structural crater
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Met prior guidance on Motor leadership + Retail Health growth. Missed overall growth momentum (7.5% GDPI vs industry 10.9%) and vastly missed profitability (guidance implied breakeven improvement, delivered -46% crash).
Cautiously Optimistic
next 1–2 quarters
Neutral
multi-year
Revenue grew 12% YoY but PAT crashed 46%, driven by Motor TP judgement provision (₹165 Cr), Fire large losses (₹63 Cr), and claim inflation in Health. Even ex-one-offs, underlying PAT declined 23%. Motor TP is structural until regulator acts on pricing. Retail Health growth is the bright spot but insufficient to offset near-term headwinds.
₹6807.9 Cr
Revenue · +12% YoY₹403.2 Cr
Reported PAT · +-46% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Strong growth momentum from H2 FY26 to continue into early FY27
OVERSTATEDGDPI 7.5% growth, vs industry 10.9%. Below prior call expectations and industry pace.
Motor and exceptional growth in Retail Health driving results
METMotor 14% in-line with industry; Retail Health 69.5% growth beats industry 31.6%. But Motor TP crater offsets gains.
Disciplined underwriting, Motor loss ratio 65-67% target
MISSMotor CoR 106.6% FY2026 (better than industry 128%), but ₹165 Cr TP provision in Q1 adds 2.8% to CoR. Discipline challenged by judgement.
Resilient Motor portfolio outperforming industry
OVERSTATEDMotor grew 14% in-line; underlying Motor TP exposure to ₹30k/month domestic care headwind is massive. Even OD vs TP split 50-50 offers limited buffer.
Earnings quality
What changed since the last call
Motor TP headwind materialized
DowngradeJune 2026 SC judgement on 'loss of domestic care' adds 12-15% to industry Motor TP loss ratio. ICICI took ₹165 Cr provision (2.8% CoR impact). Prior call was 'cautious' but not quantified.
Profitability surprise negative
DowngradePAT fell 46% YoY to ₹403 Cr despite 12% revenue growth. Even ex-fire/Motor TP, underlying PAT down 23% YoY. Margin compression across portfolio, not just one-off.
Retail Health growth remains strong
Neutral69.5% growth (vs prior call 'exceptional growth') confirmed; market share expanded to 4.5%. But loss ratio spiked on claim inflation, capping upside.
Commercial lines compression deepens
DowngradeFire de-growth worsened to 27.8% for Q1, improved to 18% by June. Management expects 'relative reduction' in aggression but no recovery guidance.
The Q&A
Analysts pressed hard on Motor TP sustainability and Health claim inflation. Management deferred repeatedly, citing 'variability' and 'early days.' CFO resisted quantifying forward impact. Sanjeev added strategic context (50-50 OD/TP split, MAD buffer) but no commitment to offset. Q&A tone: investors unconvinced by hedging.
Motor TP provision scope — Sanketh Godha, Avendus Spark
PartialHolistic assessment of all exposures as at June 30, including past periods. Prudent reserve, not just Q1. Future impact depends on regulatory outcome, price hike, and claim evolution—multiple variables.
Motor TP provision scope (clarification) — Prayesh Jain, Motilal Oswal
AnsweredHolistic assessment of all exposures on books. Similar approach to prior judgements (2021 Kirti case, etc.). Reserving triangle shows conservative approach.
Fire loss ratio normalization — Madhukar, JP Morgan
AnsweredHistorically Fire LR 65-70% average. Two large claims skewed Q1; excluding them, LR would be within historical range. Not price-driven, just catastrophic exposure.
Motor TP basis points impact — Rishi Jhunjhunwala, IIFL
DodgedImpossible to say; too many variables (regulatory outcome, ground adoption, price hike, efficiency levers). Will update each quarter.
Fire competitive intensity trajectory — Nidhesh Jain, Investec
AnsweredSoft reinsurance renewals, deregulation, excess capacity. Industry solvency dropped 1.75x to 1.56x; unsustainable. Some players pulling back. Q1 aggression easing—Fire de-growth 18% in June vs 27.8% Q1 avg. Expect relative moderation, not full recovery.
Motor TP hike adequacy — Rahil Shah, HSBC
AnsweredIndustry needs minimum TP rate revision of 12-15% to restore adequacy. Coupled with no TP change for years, revision is urgent. Regulator-dependent.
Health loss ratio durability — Rahil Shah, HSBC
PartialElevated claim incidences across industry (monsoon-related). Same pattern in Q1 last year. Will monitor for rest of quarters.
Arbitration award impact — Avinash, Emkay Global
AnsweredOld policy (7-8 years back). Award announced now but legal remedies available. Existing reserves cover; award on gross basis, net of reinsurance. No material P&L impact. Reserving philosophy unchanged.
Guidance
No explicit FY27 revenue target; growth dependent on Motor TP pricing hike resolution
LowManagement expects 'strong momentum' but 7.5% Q1 GDPI growth vs industry 10.9% suggests conservatism warranted. Fire competitive easing post-Q1 could support growth recovery.
No explicit margin target; industry Motor TP loss ratio expected to rise 12-15%, industry Motor CoR ~128% currently
Low12-15% increase implies TP pricing hike urgent, but regulator-dependent. No commitment on ICICI margin recovery path. Health claim inflation unresolved.
Risks the call surfaced
Motor TP structural headwind
HighJune 2026 SC judgement adds ~12-15% to industry Motor TP loss ratio. ICICI reserves ₹165 Cr (2.8% CoR) in Q1. Regulator TP price hike not guaranteed; even if approved, takes months to flow. Motor is 50% of ICICI portfolio.
Health claim inflation
HighQ1 retail health loss ratio spiked despite 69.5% growth; management attributes to monsoon-related claim inflation but lacks specificity. GST benefit on claims should have offset; instead LR rose. Suggests underlying claim cost increase structural.
Fire catastrophic loss recurrence
Medium₹63 Cr large losses in Fire in Q1 (1% CoR impact). Historically ICICI Fire LR never exceeded 100%; current 1% hit suggests either portfolio quality degradation or catastrophic event concentration. Fire is competitive, pricing pressure evident (de-growth 27.8%).
Commercial lines de-growth persistence
MediumCommercial segment de-grew 13.8% in Q1 despite disciplined approach; Fire particularly hard-hit (27.8% de-growth). Soft reinsurance market and pricing pressure expected to persist through H1; even if eases H2, full-year growth recovery uncertain.
Margin compression across portfolio
HighEven ex-large losses (fire + Motor TP), underlying PAT fell 23% YoY despite 12% revenue growth. CoR normalized to 102.3% but remains above prior year 102.2%. Suggests pricing power erosion and claim cost inflation are broad-based, not just Motor/Health.
Management
Score 6/10. Mixed. Transparency on one-off events but evasive on Motor TP forward impact. CFO deferred repeatedly to 'variability' and 'future quarters' when pressed for specifics. Analysts unconvinced by hedging. Underperformed prior guidance. Revenue growth 7.5% vs industry 10.9% and implied 'strong momentum.' Profitability crashed 46% YoY, a major miss. Motor leadership maintained but TP headwind unmanaged. Retail Health growth strong but unmet margin expectations.
1 · Q2 FY27 (Sep 2026)
Motor TP rate hike outcome, health claim frequency normalize post-monsoon
2 · Sep 2026
Supreme Court TP revision petition hearing; industry lobbying for 12-15% rate correction
3 · FY27 (TBD)
Regulator ruling on Motor TP commission regulations; margin implication unclear
Retail Health growth is the bright spot but insufficient to offset near-term headwinds.